Pregnane glycosides constitute a class of compounds widely distributed in the plant kingdom. Many of them have shown either anticarcinogenic or cancer inhibitory properties, besides other useful biological activities. New chromatographic techniques and advances in spectroscopic and spectrometric methods have accelerated the purification and structure determination of novel glycosides of this series. A compilation of the pregnane glycosides isolated from 1995 until the middle of 2005, along with their physical data, structures and occurrence are presented in this review, which also summarizes, with suitable examples, recent developments in isolation and purification techniques, and structural elucidation using modern spectrometric methods like ESIMS and tandem mass spectrometry, and 2D NMR spectroscopic strategies. The reported anticancer and other biological activities of pregnane glycosides are also discussed.
CoxPA, BalickMJ. (1994) The ethnobotanical approach to drug discovery. Scientific American, 270, 82–87.
2.
LechpenbergM, NahrstedtA. (1999) Cyanogenic glycosides. In Naturally Occurring Glycosides, IkanR. (Ed). John Wiley & Sons, Chichester. 147–191.
3.
WilliamsLJ, GarbaccioRM, DanishefskySJ. (2000) Interative assembly of glycals and glycal derivatives: The synthesis of glycosylated natural products and complex oligosaccharides. In Carbohydrates in Chemistry and Biology. Vol. 1, ErnstB, HartGW, SinaÿP. (Eds). Wiley-VCH, Weinheim. 61–93.
4.
HarveyA. (2000) Strategies for discovering drugs from previously unexplored natural products. Drug Discovery Today, 5, 294–300.
5.
ShuY-Z. (1998) Recent natural products based drug development: A pharmaceutical industry perspective. Journal of Natural Products, 61, 1053–1071.
6.
VerpoorteR. (1998) Exploration of nature's chemodiversity: The role of secondary metabolites as leads in drug development. Drug Discovery Today, 3, 232–238.
7.
GrableyS, ThierickeR. (1999) The impact of natural products on drug discovery. In Drug Discovery from Nature. GrableyS, ThierickeR (Eds). Springer-Verlag, Heidelberg, Germany. 3–37
8.
HarveyA, WatermanEG. (1998) The continuing contribution of biodiversity to drug discovery. Current Opinion in Drug Discovery Development, 1, 71–76.
9.
WollenweberE, JayM. (1988) Flavones and flavonols. In Flavonoids. HarborneJB (Ed). Chapman & Hall, London, UK, 233–302.
10.
SharmaGVM, KrishnaPR. (2004) Carbohydrates: from ‘Chirons’ to new glycosubstances. Current Organic Chemistry, 8, 1187–1209.
11.
BoydMR. (1996) The position of intellectual property rights in drug discovery and development from natural products. Journal of Ethnopharmacology, 51, 17–27.
12.
LipinskiCA, LonbardoF, DominyBW, FeeneyPJ. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23, 3–25.
13.
SahuNP, AchariB. (2001) Advances in structural determination of saponins and terpenoid glycosides. Current Organic Chemistry, 5, 315–334.
14.
MacilwainC. (1998) When rhetoric hits reality in debate on bioprospecting. Nature, 392, 535–540.
15.
WilliamsDH, StoneMJ, HauckPR, RahmanSK. (1989) Why are secondary metabolites (natural products) biosynthesized. Journal of Natural Products, 52, 1189–1208.
16.
ReichsteinT. (1967) Cardenolid- und pregnanglykoside. Naturwissenschaften, 54, 53–67.
17.
WettsteinPA. (1961) Biosynthèse des hormones stéroïds. Experientia, 17, 329–376.
18.
HeftmannE. (1974) Recent progress in the biochemistry of plant steroids other than sterols (saponins, glycoalkaloids, pregnane derivatives, cardiac glycosides and sex hormones). Lipids, 9, 626–639.
19.
YamauchiT. (1985) Cardinolides, pregnanes and iridoids characteristics of Apocynaceae plants. Yakugaku Zasshi, 105, 695–712.
20.
MeleroCP, MedardeM, FelicianoAS. (2000) A short review on cardiotonic steroids and their amino guanidine analogues. Molecules, 5, 51–81.
DeepakD, SrivastavS, KhareA. (1997) Pregnane Glycosides, In Progress in the Chemistry of Organic Natural Products. Vol. 71, HerzW, KirbyWGW, MooreRE, SteglichW and TammC. (Eds) Springer, Wien, New York. 169–325.
23.
JiaZ, KoikeK, SahuNP, NikaidoT. (2002) Triterpenoid Saponins from Caryophyllaceae Family, In Studies in Natural Products Chemistry. Vol. 26, Atta-ur-Rahman, (Ed) Elsevier, Amsterdam. 3–61.
24.
UmeharaK, Sumii (née Shirasu)N, SatohH, MiyaseT, KuroyanagiM, UenoA. (1995) Studies on differentiation inducers V. Steroid glycosides from Periplocae radicis cortex. Chemical and Pharmaceutical Bulletin, 43, 1565–1568.
25.
KanchanapoomT, KasaiR, OhtaniK, AndriantsiferanaM, YamasakiK. (2002) Pregnane and pregnane glycosides from the Malagasy plant, Cynanchum aphyllum. Chemical and Pharmaceutical Bulletin, 50, 1031–1034.
26.
BracaA, BaderA, MorelliI, ScarpatoR, TurrchiG, PizzaC, TommasiND. (2002) New pregnane glycosides from Caralluma negevensis. Tetrahedron, 58, 5837–5848.
27.
ZhangQ, ZhaoY, WangB, LiuX, ChengT. (2002) New pregnane glycosides from Stelmatocrypton khasianum. Steroids, 67, 347–351.
28.
YoshikawaK, MatsuchikaK, TakahashiK, TanakaM, AriharaS, ChangHC, WangJD. (1999) Pregnane glycosides, gymnepregosides G-Q from the roots of Gymnema alternifolium. Chemical and Pharmaceutical Bulletin, 47, 798–804.
29.
LeeKY, SungH, KimYC. (2003) New acetyl cholinesterase-inhibitory pregnane glycosides of Cynanchum atratum roots. Helvetica Chimica Acta, 86, 474–483.
30.
AbeF, HirokawaM, YamauchiT, HondaK, HayashiN, NishidaR. (1999) Glycosides of 14,15-seco-and 13,14: 14,15-diseco pregnanes from the roots of Tylophora tanakae. Chemical and Pharmaceutical Bulletin, 47, 1384–1387.
31.
YeoH, ChotY, KimJ. (2002) New pregnane glycosides from Cynanchum ascyrifolium. Chemical and Pharmaceutical Bulletin, 50, 847–849.
32.
YeoH, KimK-W, KimJ, ChoiY-H. (1998) Steroidal glycosides of the 14,15-seco-18-nor-pregnane series from Cynanchum ascyrifolium. Phytochemistry, 49, 1129–1133.
33.
LavaultM, RichommeP, BrunetonJ. (1999) Acetophenones and new pregnane glycosides from the roots of Vincetoxicum hirundinaria. Fitoterapia, 70, 216–220.
34.
ItokawaH, XuJ, TakeyaK. (1988) Studies on chemical constituents of antitumor fraction from Periploca sepium. IV. Structures of new pregnane glycosides, periplocosides D, E, L, and M. Chemical and Pharmaceutical Bulletin, 36, 2084–2089.
35.
ItokawaH, XuJ, TakeyaK. (1988) Studies on chemical constituents of antitumor fraction from Periploca sepium. V. Structures of new pregnane glycosides, periplocosides J, K, F and O. Chemical Pharmaceutical Bulletin, 36, 4441–4446.
36.
RangaswamiS, ReichsteinT. (1949) Konstitution von odorosid A und odorosid B. die glykoside von Nerium odorum Sol., 2. mitteilung. glykoside und aglykone, 45. mitteilung. Helvetica Chimica Acta, 32, 939–949.
37.
DeepakD, KhareMP, KhareA. (1986) A new pregnane glycoside from Periploca calophylla. Indian Journal of Chemistry, 25B, 44–45.
AbeF, YamauchiT. (1988) Pregnane glycosides from Trachelospermum asiaticum. Chemical and Pharmaceutical Bulletin, 36, 621–626.
40.
JinQD, ZhouQL, MuQZ. (1989) Two new pregnane oligoglycosides from Dregea sinensis var. corrugata. Journal of Natural Products, 52, 1214–1220.
41.
HuanVD, OhtaniK, KasaiR, YamasakiK, TuuNV. (2001) Sweet pregnane glycosides from Telosma procumbens. Chemical and Pharmaceutical Bulletin, 49, 453–460.
42.
VleggaarR, HeerdenFRV, AndersonLAP, ErasmusGL. (1993) Toxic constituents of the Asclepiadaceae. Structure elucidation of sarcovimiside A-C of Sarcostemma viminale. Journal of the Chemical Society. (Perkin Transections I), 483–487.
43.
WarashinaT, NoroT. (2000) Steroidal glycosides from the aerial part of Asclepias incarnata. Phytochemistry, 53, 485–498.
44.
NakanishiT, KobayashiM, MurataH, InadaA. (1988) Phytochemical studies on meliaceous plants .4. Structure of a new pregnane glycoside, toosendanoside, from leaves of Melia toosendan SIEB. Et ZUCC. Chemical and Pharmaceutical Bulletin, 36, 4148–4152.
45.
FujimotoH, SuzukiK, HigiwaraH, YamazakiM. (1986) New toxic metabolites from a mushroom, Hebeloma vinosophyllum I. Structure of hebelovinosides I, II, III, IV and V. Chemical and Pharmaceutical Bulletin, 34, 88–99.
ChenZ-S, LaiJ-S, KuoY-H. (1991) Cynanformosides A & B, two new pregnane glycosides, from the aerial part of Cynanchum formosanum. Chemical and Pharmaceutical Bulletin, 39, 3034–3036.
48.
KlyneW. (1950) The configuration of the anomeric carbon atoms in some cardiac glycosides. Biochemical Journal, 47, xli–xlii.
HayashiK, IidaI, NakaoY, KanekoYK. (1988) Four pregnane glycosides, boucerosides AI, AII, BI and BII from Boucerosia aucheriana. Phytochemistry, 27, 3919–3924.
51.
TsukamotoS, HayashiK, KanekoK, MitsuhashiH. (1986) Studies on the constituents of Asclepiadaceae plants. LXV. The optical resolution of D- and L-cymaroses. Chemical and Pharmaceutical Bulletin, 34, 3130–3134.
52.
WilliamsDH, BradleyG, BojesenG, SantokaranS, TaylorLCE. (1981) Fast atom bombardment mass spectrometry: A powerful technique for the study of polar molecules. Journal of the American Chemical Society, 103, 5700–5704.
53.
FenselauC. (1984) Fast atom bombardment and middle molecule mass spectrometry. Journal of Natural Products, 47, 215–225.
54.
LattimerRP, SchultenHR. (1989) Field ionization and field desorption mass spectrometry: past, present and future. Analytical Chemistry, 61, 1201A–1215A.
55.
SundvistB, RoepstorffP, FohlmanJ, HedinA, HakanssonP, KamenskyM, LindbergM, SalehpoourM, SaveG. (1984) Molecular weight determinations of proteins by californium plasma desorption mass spectrometry. Science, 226, 696–698.
56.
SahuNP, PandaN, MandalNB, BanerjeeS, KoikeK, NikaidoT. (2002) Polyoxypregnane glycosides from the flowers of Dregea volubilis. Phytochemistry, 61, 383–388
57.
KarasM, HillenkampF. (1988) Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry, 60, 2299–2301.
58.
LiangF, LiL-J, AblizZ, YangYC, ShiJG. (2002) Structural characterization of steroidal saponins by electrospray ionization and fast-atom bombardment tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 16, 1168–1173
59.
LiuS, CuiM, LiuZ, SongF, MoW. (2004) Structural analysis of saponins from medicinal herbs using electrospray ionization tandem mass spectrometry. Journal of the American Society of Mass Spectrometry, 15, 133–141.
60.
SongF, CuiM, LiuZ, YuB, LiuS. (2004) Multiple-stage tandem mass spectrometry for differentiation of isomeric saponins. Rapid Communications in Mass Spectrometry, 18, 2241–2248.
61.
FangS, HaoC, SunW, LiuZ, LiuS. (1998) Rapid analysis of steroidal saponin mixture using electrospray ionization mass spectrometry combined with sequential tandem mass spectrometry. Rapid Communications in Mass Spectrometry, 12, 589–594
62.
Dal PiazF, De LeoM BA, De SimoneF, MorelliI, De TommasiN. (2005) Electrospray ionization mass spectrometry for identification and structural characterization of pregnane glycosides. Rapid Communications in Mass Spectrometry, 19, 1041–1052.
63.
BhaccaNS, WilliamsDH. (1964) Application of NMR Spectroscopy in Organic Chemistry: Holden Day, San Francisco
64.
MukherjeeA, BanerjeeS, MahatoSB. (1982) Metabolism of progesterone by Aspergillus fumigatus. Journal of Steroid Biochemistry, 17, 443–446.
ShibuyaH, ZhangR, ParkZE, BaekNI, TakedaY, YoshikawaM, KitagawaI. (1992) Indonesian medicinal plants: V. Chemical structures of calotroposides C, D, E, F, and G: Five additional new oxypregnane-oligoglycosides from the root of Calotropis gigantean (Asclepiadaceae). Chemical and Pharmaceutical Bulletin, 40, 2647–2653.
71.
BergerS, JuniorP, KopanskiL. (1988) Structural revision of pregnane ester glycosides from condurango cortex and new compounds. Phytochemistry, 27, 1451–1458.
72.
AgrawalPK. (1992) NMR spectroscopy in the structural elucidation of oligosaccharides and glycosides. Phytochemistry, 31, 3307–3330
73.
Al-YahyaMAA, Abdel-SattarE, GuittetE. (2000) Pregnane glycosides from Caralluma russeliana. Journal of Natural Products, 63, 1451–1453.
74.
EggertH, AntwerpCL, BhaccaNS, DjerassiC. (1976) Carbon-13 nuclear magnetic resonance spectra of hydroxy steroids. Journal of Organic Chemistry, 41, 71–81.
YeY, SunH, LiX, ChenF, QinF, PanY. (2005) Four new C-21 steroidal glycosides from the roots of Stephanotis mucronata and their immunological activities. Steroids, 70, 791–797.
77.
LiuH, XiongZ, LiF, QuG, KobayashiH, YaoX. (2003) Two new pregnane glycosides from Dioscorea futschauensis R. Kunth. Chemical and Pharmaceutical Bulletin, 51, 1089–1091.
78.
HuK, YaoX-S, DongA-J, KobayashiS, JingY-K (1999) A new pregnane glycoside from Dioscorea collettii var. hypoglauca. Journal of Natural Products, 62, 299–301
79.
GottesmanMM, PastanI. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annual Review of Biochemistry, 62, 385–427.
80.
ChungSY, SungMK, KimNH, JangJO, GoEJ, LeeHJ (2005) Inhibition of P-glycoprotein by natural products in human breast cancer cells, Archives of Pharmalogical Research, 28, 823–828.
81.
RadelS, BankusliI, MayhewE, RustumYM. (1988) The effects of verapamil and a tiapamil analogue, DMDP, on adriamycin-induced cytotoxicity in P388 adriamycin-resistant and -sensitive leukemia in vitro and in vivo. Cancer Chemotherapy and Pharmacology, 21, 25–30.
82.
MillerTP, GroganTM, DaltonWS, SpierCM, ScheperRJ, SalmonSE. (1991) P-glycopreotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. Journal of Clinical Oncology, 9, 17–24.
83.
TwentymanD, FoxN, WhiteD. (1987) Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. British Journal of Cancer, 56, 55–57
84.
KellerRP, AltermattHJ, NooterK, PorschmannG, LaissueJA, BollingerP, HiestandPC. (1992) SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia. International Journal of Cancer, 50, 593–597.
85.
YangCPH, DePinhoSG, GreenbergerLM, ArceclRJ, HorwitzSB. (1989) Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. Journal of Biological Chemistry, 264, 782–788.
86.
NaitoM, YusaK, TsuruoT. (1989) Steroid hormones inhibit binding of Vinca alkaloid to multidrug resistance related P-glycoprotein. Biochemistry and Biophysics Research Communication, 158, 1066–1071.
87.
TrumpDL, SmithDC, EllisPG, RogersMP, ScholdSC, WinerEP, PanellaTJ, JordanVC, FineRL. (1992) High-dose oral Tamoxifen, a potential multidrug-resistance-reversal agent: Phase I trial in combination with vinblastine. Journal of National Cancer Institute, 84, 1811–1816.
AhsanAM, PiatakDM, SorensaenPD. (1973) Isolation and structure of amplexoside A. A new glycoside from Asclepias amplexicaulis. Experientia, 29, 788–789.
90.
YoshimuraS, NaritaH, HayashiK, MitsuhashiH. (1983). Studies on the constituents of Asclepiadaceae plants. LVI. Isolation of new antitumor-active glycosides from Dregea volubilis (L) Benth. Chemical and Pharmaceutical Bulletin, 31, 3971–3983.
91.
MurmuN, GhoshP, GomesA, MitraS, DasM, BesraSE, MujumderJ, BhattacharyaS, SurP, VedasiromoniJR. (2002). Antineoplastic effect of new born compounds against leukemic cell lines and cells from leukemic patients. Journal of Experimental and Clinical Cancer Research, 21, 351–356.
Abdel-SayedA, BauerL. (1986) Polarization transfer via long range couplings a simple one-dimensional NMR technique for 1H-13C correlation. Application to the definitive assignment of the syn and anti 13C δ resonances of 2-substituted adamantanes. Tetrahedron Letters, 27, 1003–1006.
SchunY, CordellGA. (1987) Cytotoxic steroids of Gelsemium sempervirens. Journal of Natural Products, 50, 195–198.
96.
GeranRI, GreenbergNH, McDonaldMM, SchumacherAM, AbbottBJ (1972) Protocol for screening chemical agents and natural products against animal tumors and other biological systems. Cancer Chemotherapy Report, 3, 1–103.
97.
FreireichEJ, GehandEA, RallDP, SchmidtLH, SkipperHE. (1966) Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemotherapy Report, 50, 219–244.
98.
ItokawaH, XuJ, TakeyaK, WatanabeK, ShojiJ. (1988) Studies on chemical constituents of antitumor fraction from Periploca sepium II. Structures of new pregnane glycosides, Periplocosides A, B and C. Chemical and Pharmaceutical Bulletin, 36, 982–987.
ArisawaM, PezzutoJ.M, BevelleC, CordellGA. (1984) Potential anticancer agents XXXI. N-Demethylation of fagaronine. Journal of Natural Products, 47, 453–458.
101.
LeoMD, TommasiND, SanogoR, AutoreG, MarzoccoS, PizzaC, MorelliI, BracaA. (2005) New pregnane glycosides from Caralluma dalzielii. Steroids, 70, 573–585.
102.
MosmannT. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods, 65, 55–63.
103.
GreenM, ReadeJL, WareCF. (1984) Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhitory lymphokines. Journal of Immunological Methods, 70, 257–268.
104.
OpipariAWJ, HuHM, YabkowitzR, DixitVM. (1992) The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. Journal of Biological Chemistry, 267, 12424–12427.
105.
HayashiK, WadaK, MitsuhashiH, BandoH, TakaseM, TeradaS, KoideY, AibaT, NaritaT, MizunoD. (1980) Antitumor active glycoside from Condurango cortex. Chemical and Pharmaceutical Bulletin, 28, 1954–1958; idem (1981) Further investigation of antitumor Condurango glycosides with C-18 oxygenated aglycone. Chemical and Pharmaceutical Bulletin, 29, 2725–2730.
106.
SachsL. (1978) Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemia. Nature (London), 274, 535–539.
107.
SaribanE, MitchellT, KufeD. (1985) Expression of the c-fms proto-oncogene during human monocytic differentiation. Nature (London), 316, 64–66.
108.
HuangM, YeY, ChenS, ChaiJ, LuJ, ZhoaL, GuL, WangZ. (1988) Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567–572.
109.
UmeharaK, EndohM, MiyaseT, KuroyanagiM, UenoA. (1994) Studies on differentiation inducers. IV. Pregnane derivatives from Condurango cortex. Chemical and Pharmaceutical Bulletin, 42, 611–616.
110.
SelkoeDJ. (1994) Normal and abnormal biology of the beta-amyloid precursor protein. Annual Review of Neuroscience, 17, 489–517.
111.
WeinstockM. (1995) The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update, Neurodegeneration, 4, 349–356.
112.
HollanderE, MohsRC, DavisKL. (1986) Cholinergic approaches to the treatment of Alzheimer's disease. British Medical Bulletin, 42, 97–100.
113.
PiacenteS, BelisarioAB, CastilloHD, PizzaC, FeoVD. (1998) Croton ruizianus: platelet proaggregating activity of two new pregnane glycosides. Journal of Natural Products, 61, 318–322.
114.
BergmeyerHU, BerntE. (1974) Methods of enzymatic analysis, Academic Press, New York, US. Vol 2, 574–582.
115.
OshimaY, HirotaT, HikinoH. (1987) Periplosides A, B and C, steroidal glycosides of Periploca sepium root barks. Heterocycles, 26, 2093–2098.
116.
WagnerU, BurkhardiE, FailingK. (1999) Evaluation of canine lymphocyte proliferation: comparison of three different colorimetric methods with the 3H-thymidine incorporation assay. Veterinary Immunology and Immunophathology, 70, 151–159.
117.
KimNC, KinghornAD. (2002) Highly sweet compounds of plant origin. Archives of Pharmacological Research, 25, 725–46.
118.
DuBoisGE, WaltersDE, SchiffmanSS, WarwickZS, BothBJ, PecoreSD, GibesK, CarrBT, BrandsLM. (1991) Concentration-response relantionships of sweeteners. In: Sweeteners: Discovery, Molecular Design and Chemoreception, WaltersDE, OrthoeterFT, DuboisGE (Eds). American Chemical Society, Washington, DC, 261–276
119.
DariseM, MizutaniK, KasaiR, TanakaO, KitahataS, OkadaS, OgawaS, MurakamiF, ChenFH. (1984) Enzymic transglucosylation of rubusoside and the structure-sweetness relationship of steviol-bisglycosides. Agricultural and Biological Chemistry, 48, 2483–2488.
120.
JinJM, LiuXK, YangCR. (2002) A new pregnane glycoside from fermented leaves of Agave americana. Chinese Chemical Letters, 13, 1189–1192.
121.
KamelMS, KoskinenA. (1995) Pregnane glycosides from fruits of Balanites aegyptiaca. Phytochemistry, 40, 1773–1775.
AbeF, FujishimaH, IwaseY, YamauchiT, KinjoK, YagaS. (1999) Pregnanes and pregnane glycosides from Hoya carnosa. Chemical and Pharmaceutical Bulletin, 47, 1128–1133.
132.
GuptaVS, KumarA, DeepakD, KhareA, KhareNK. (2003) Pregnanes and pregnane glycosides from Marsdenia roylei. Phytochemistry, 64, 1327–1333.
133.
XiaZ-H, XingW-X, MaoS-L, LaoA-N, UzawaJ, YoshivaS, FugimotoY. (2004) Pregnane glycosides from the stems of Marsdenia tenacissima. Journal of Asian Natural Product Research, 6, 79–85.
134.
AbeF, YamauchiT, HondaK, HayashiN. (2000) Marstomentosides O-T, polyoxypregnane glycosides from Marsdenia tomentosa. Chemical and Pharmaceutical Bulletin, 48, 154–156.
135.
AbeF, OkabeH, YamauchiT, HondaK, HayashiN. (1999) Pregnane glycosides from Marsdenia tomentosa. Chemical and Pharmaceutical Bulletin, 47, 869–875.
136.
WarashinaT, NoroT. (1998) Steroidal glycosides from the roots of Metaplexis japonica. Phytochemistry, 49, 2103–2108.
137.
HamedAI, ShededMG, ShaheenAEM, HamadaFA, PizzaC, PiacenteS. (2004) Polyhydroxypregnane glycosides from Oxystelma esculentum var. alpini. Phytochemistry, 65, 975–980.
138.
ChenX, JiaZJ. (2000) Two new glycosides from Rubus amabilis. Chinese Chemical Letters, 11, 897–900.
139.
ChenJ-J, ZhangZ-X, ZhouJ, LiB-T. (1999) New pregnane glycosides from Sinomarsdenia incisa. Journal of Natural Products, 62, 829–832.
140.
PlazaA, PiacenteS, PerroneA, HamedA, PizzaC, BifulcoG. (2004) Stemmosides C and D, two novel unusual pregnane glycosides from Solenostemma argel: Structural elucidation and configurational study by a combined NMR-quantum mechanical strategy. Tetrahedron, 60, 12201–12209.
141.
YoshikawaK, OkadaN, KannY, AriharaS. (1996) Chemical structures of stephenosides A-J. Chemical and Pharmaceutical Bulletin, 44, 1790–1796.
142.
YeY, LiX, SunH, ChenF, PanY. (2004) Immunomodulating steroidal glycosides from the roots of Stephanotis mucronata. Helvetica Chimica Acta, 87, 2378–2384.
143.
YokosukaA, MimakiY, SashidaY (2002) Steroidal and pregnane glycosides from the rhizomes of Tacca chantripri. Journal of Natural Products, 65, 1293–1298.
